B2M and classic Hodgkin lymphoma: In an examination of B2M protein expression in a large cohort of cHL tumors by immunohistochemistry, it was observed that B2M loss was more common in younger patients (median age 30 vs. 47, p<0.0001), suggesting that this mutation may be a feature of cHL in children and AYAs (15).